A Comparative Pharmacokinetic Profiles of Three Urolithin A Formulations in Healthy Volunteers: A Randomized, Open-label, Single-dose, Parallel-arm Study
This study's design as an open-label, single-dose, randomized trial that aligns with the objective of characterizing the concentration-time profiles of three Urolithin A (Mitopure) formulations in a controlled setting. The inclusion criteria, stringent fasting requirements, standardized fluid intake and strict dietary restriction protocols ensure homogeneity among the study participants, enhancing the reliability of the outcomes.
Ultimately, this clinical trial aims to contribute valuable insights into the pharmacokinetic behavior of the different Urolithin A formulations, facilitating informed decisions for future developments and applications in the realm of health and wellness.
To study the safety and efficacy of Panchakarma Essential (Katibasti) in the management of lowerback pain. - Nil
A Clinical Study to Evaluate the Safety and Efficacy of Panchakarma Essential in female patients with generalized anxiety disorder - NIL
100 Clinical Results associated with Mprex Healthcare Pvt. Ltd.
0 Patents (Medical) associated with Mprex Healthcare Pvt. Ltd.
100 Deals associated with Mprex Healthcare Pvt. Ltd.
100 Translational Medicine associated with Mprex Healthcare Pvt. Ltd.